51 Scoping review pediatric patient engagement Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Jordan [126] 2020 Canada 1 Unknown 17 17 8 Clinical care Kada [127] 2019 Norway 22 Radiology 8 16 1 Clinical care Karande [128] 2005 India 50 Hospital admission 5 12 1 Clinical care Karnieli-Miller [129] 2009 Israel 13 Gastrointestinal diseases 9;6 16;6 1 Clinical care Kaziunas [130] 2016 United States 17 Transplantation NR NR 1 Clinical care Kebbe [131] 2019 Canada 19 Obesity 13 17 1 Clinical care Kebbe [132] 2019 Canada 19 Obesity 13 17 1 Clinical care Kelly [133] 2017 United States 29 Oncology 9 17 1,8 Clinical care Kelsey [134] 2007 United Kingdom 10 Multiple disease groups 13 16 1 Clinical care Kiernan [135] 2005 Ireland 240 Multiple disease groups 7 16 7 Clinical care King [136] 2020 Canada 10 Neuromuscular disorders 8 18 1 Clinical care Klassen [137] 2015 Canada 38 Oncology 15 26 1 Intervention development Kleye [138] 2020 Sweden 13 Multiple disease groups 4 12 1,8 Clinical care Klosinski [139] 2015 Germany 22 Multiple disease groups 12 17 1,2 Intervention development Klostermann [140] 2005 United States 54 Multiple disease groups 11 19 2 Clinical care Koller [141] 2016 Canada 26 Multiple disease groups 5 18 1 Intervention development Koller [142] 2018 Canada 14 Multiple disease groups 9 17 2 Clinical care Koller [143] 2010 Canada 21 Multiple disease groups 5 19 1 Clinical care Koller [144] 2006 Canada 5 Severe Acute Respiratory Syndrome 6 18 1 Clinical care Kortesluoma [145] 2008 Finland 44 Hospital admission 4 11 1 Clinical care Korus [146] 2015 Canada 21 Transplantation 12 18 1 Clinical care Kulandaivelu [147] 2018 Canada 19 Sickle cell disease 12 19 1 Clinical care Lam [148] 2017 China 25 Oncology 9 18 1 Clinical care Lambert [149] 2008 Ireland 49 Hospital admission 6 16 3,8 Clinical care Lambert [150] 2013 Ireland 49 Hospital admission 6 16 3,8 Clinical care 2
RkJQdWJsaXNoZXIy MTk4NDMw